DISTAL COMPLEMENT COMPONENTS IN IMMUNE RENAL INJURY
免疫性肾损伤中的远端补体成分
基本信息
- 批准号:3566180
- 负责人:
- 金额:$ 30.06万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1985
- 资助国家:美国
- 起止时间:1985-03-01 至 1995-02-28
- 项目状态:已结题
- 来源:
- 关键词:affinity chromatography antibody formation antigen receptors antiserum autoantigens autoimmune disorder basement membrane brush border membrane complement complement inhibitors complement pathway disease /disorder model enzyme linked immunosorbent assay extracellular matrix gene expression glomerulonephritis immune complex immune complex diseases immunofluorescence technique immunoglobulin G inflammation laboratory mouse laboratory rabbit laboratory rat laminin macrophage membrane activity membrane permeability membrane proteins messenger RNA metalloenzyme nephritis nephrotic syndrome neutrophil peptidases protein biosynthesis proteinuria renal tubular transport renal tubule synthetic peptide western blottings zinc
项目摘要
Membranous nephropathy (MN) is the commonest cause of idiopathic nephrotic
syndrome in adults and is a prototype of immune complex induced
glomerulonephropathy. The subepithelial deposits which characterize MN in
vivo form locally as a consequence of A) antibody binding to antigen(s) on
the glomerular epithelial cell (GEC) surface, or B) charge interaction
between cationic antigens or antibodies and glomerular anionic sites
followed by in situ immune complex formation. The consequences of
subepithelial immune deposit formation by both mechanisms include a marked
increase in glomerular permeability accompanied by an increase in basement
membrane (GBM) thickness due to accumulation of excess normal matrix
components produced by the GEC, particularly laminin. Studies in
experimental models of MN induced by both of these mechanisms have
documented that the complement membrane attack complex, C5b-9, mediates
proteinuria in MN, presumably through insertion into the GEC membrane.
This project will examine the cellular and molecular consequences of C5b-9
attack on the GEC which may lead to the functional and structural
glomerular abnormalities of MN. Three hypotheses will be tested. 1) That
GEC C5b-9 attack results in altered synthesis of extracellular matrix
components. The effect of C5b-9 attack on GEC in culture on GEC synthesis
of type IV collagen, laminin, heparan sulfate proteoglycans and entactin
will be studied utilizing metabolic labeling, direct measurement of product
in cell supernatant and cell layer/matrix and measurement of GEC mRNA
encoding for type IV collagen and laminin. C5b-9 attack on antibody
sensitized cultured GEC (analogous the autoimmune mechanism of MN) will be
compared to C5b-9 attack on non-sensitized GEC (analogous to exogenous
antigen induced MN). 2) The hypothesis that altered GBM permeability in MN
results from GEC production of a neutral serine proteinase will be tested
by isolating and characterizing a proteinase produced by GEC and measuring
the effect of GEC C5b-9 attack on production of this proteinase. 3) The
hypothesis that C5b-9 attack on GEC induces proteinuria by causing GEC
detachment from basement membrane will be tested by studying the effect of
C5b-9 attack initiated by the two mechanisms above on GEC attachment to, or
detachment from, various extracellular matrices, and by examining the
effect of C5b-9 attack on GEC membrane attachment receptors. The results
of these studies should clarify the cellular and molecular basis for
glomerular injury induced by C5b-9 in MN as well as in other antibody
initiated glomerular diseases.
膜性肾病(MN)是特发性肾病的最常见原因
成人综合征,是免疫复合物诱导的原型
肾小球肾脏病。 表征Mn的上皮下沉积物
由于A)抗体结合与抗原的抗原在本地形式
肾小球上皮细胞(GEC)表面或b)电荷相互作用
阳离子抗原或抗体和肾小球阴离子位点之间
其次是原位免疫复合物的形成。 后果
通过这两种机制形成上皮下皮免疫沉积物
肾小球渗透性增加,伴随着地下室的增加
由于过量正常基质的积累而导致的膜(GBM)厚度
GEC产生的成分,尤其是层粘连蛋白。 研究
这两种机制诱导的MN的实验模型都有
记录了补体膜攻击综合体C5B-9,介导
MN中的蛋白尿,大概是通过插入GEC膜中的。
该项目将检查C5B-9的细胞和分子后果
对GEC的攻击可能导致功能和结构性
Mn的肾小球异常。 将检验三个假设。 1)那
GEC C5B-9攻击导致细胞外基质的合成改变
成分。 C5B-9攻击对文化中GEC对GEC合成的影响
IV型胶原蛋白,层粘连蛋白,硫酸乙酰肝素蛋白聚糖和Entactin
将研究使用代谢标签,直接测量产品的研究
在细胞上清液和细胞层/基质中以及GEC mRNA的测量
编码IV型胶原蛋白和层粘连蛋白。 C5B-9对抗体的攻击
敏化的培养GEC(类似于MN的自身免疫机制)将是
与C5B-9对非敏化GEC的攻击相比(类似于外源
抗原诱导的Mn)。 2)MN中GBM渗透性改变的假设
将测试中性丝氨酸蛋白酶的GEC产生的结果
通过隔离和表征GEC产生的蛋白酶并测量
GEC C5B-9攻击对该蛋白酶产生的影响。 3)
C5B-9对GEC的攻击通过引起GEC诱导蛋白尿的假设
从地下膜分离将通过研究
C5B-9攻击是由上述两种机制对GEC附着到或
从各种细胞外矩阵中分离,并检查
C5B-9攻击对GEC膜附着受体的影响。 结果
这些研究应阐明细胞和分子基础
C5B-9在MN以及其他抗体中诱导的肾小球损伤
引发的肾小球疾病。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
WILLIAM G COUSER其他文献
WILLIAM G COUSER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('WILLIAM G COUSER', 18)}}的其他基金
ROLE OF SPARC IN THE MODULATION OF GLOMERULAR INJURY
SPARC 在调节肾小球损伤中的作用
- 批准号:
6357047 - 财政年份:2000
- 资助金额:
$ 30.06万 - 项目类别:
ROLE OF SPARC IN THE MODULATION OF GLOMERULAR INJURY
SPARC 在调节肾小球损伤中的作用
- 批准号:
6201899 - 财政年份:1999
- 资助金额:
$ 30.06万 - 项目类别:
ROLE OF SPARC IN THE MODULATION OF GLOMERULAR INJURY
SPARC 在调节肾小球损伤中的作用
- 批准号:
6105586 - 财政年份:1998
- 资助金额:
$ 30.06万 - 项目类别:
ROLE OF SPARC IN THE MODULATION OF GLOMERULAR INJURY
SPARC 在调节肾小球损伤中的作用
- 批准号:
6239129 - 财政年份:1997
- 资助金额:
$ 30.06万 - 项目类别:
相似国自然基金
Tfh细胞调节自身抗体形成在溃疡性结肠炎体液免疫应答中的作用
- 批准号:81170361
- 批准年份:2011
- 资助金额:50.0 万元
- 项目类别:面上项目
胞内化抗体介导的HBcAg去功能化抑制HBV核壳体形成的机制研究
- 批准号:81070335
- 批准年份:2010
- 资助金额:32.0 万元
- 项目类别:面上项目
老年性和致病性II型胶原位点自身抗体形成机理探讨
- 批准号:39870857
- 批准年份:1998
- 资助金额:11.0 万元
- 项目类别:面上项目
相似海外基金
cGMP manufacturing of PBI-220, a broad spectrum immunoadhesin therapeutic against
PBI-220 的 cGMP 生产,一种广谱免疫粘附素治疗药物
- 批准号:
8076969 - 财政年份:2011
- 资助金额:
$ 30.06万 - 项目类别:
cGMP manufacturing of PBI-220, a broad spectrum immunoadhesin therapeutic against
PBI-220 的 cGMP 生产,一种广谱免疫粘附素治疗药物
- 批准号:
8461222 - 财政年份:2011
- 资助金额:
$ 30.06万 - 项目类别:
cGMP manufacturing of PBI-220, a broad spectrum immunoadhesin therapeutic against
PBI-220 的 cGMP 生产,一种广谱免疫粘附素治疗药物
- 批准号:
8262149 - 财政年份:2011
- 资助金额:
$ 30.06万 - 项目类别: